Novavax up after raising annual revenue forecast

Sanofi SA

26/02/2026 13:50

** Shares of vaccine maker Novavax NVAX.O rise 4.4% to $9.9 premarket

** Co raises revenue forecast for 2026; now expects adjusted revenue of $230 million to $270 million from $185 million to $205 million earlier

** Forecast excludes sales and royalties from partnership with Sanofi SASY.PA

** NVAX reports profit of $18 million for Q4, compared to a loss of $81 million a year ago

** Posts Q4 revenue of $147 million, beating analysts' average estimate of $78.84 million, according to data compiled by LSEG

** Stock up 41% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))